PPI Use and Its Significant Association With an Increased Incidence of Intestinal Behçet Disease

Abstract

I read with interest the recent publication by Murakami and colleagues on the association between proton pump inhibitors (PPIs) and the risk of intestinal Behçet disease (BD).¹ The authors demonstrated a significant association between PPI use and increased incidence of intestinal BD in patients with BD.